Bandhan Healthcare Fund
Pharma and Healthcare · Direct plan · Growth
₹11.69
+₹0.08 (+0.71%) today
NAV on 20 Nov 2026 · Near its 52-week high
Returns
Up to a year
| Period | This fund | BSE Healthcare | Rank |
|---|---|---|---|
| 1 month | +10.22% | +11.49% | 15/19 |
| 3 months | +3.17% | +5.00% | 14/18 |
| 6 months | +11.81% | +11.71% | 13/18 |
| This year | +19.22% | +21.57% | 14/18 |
| 1 year | – | +19.35% | – |
Longer term
| This fund | BSE Healthcare | BSE Healthcare | Category | ||||
|---|---|---|---|---|---|---|---|
| Total | A year | Total | A year | A year | Rank | ||
| 2 years | – | – | +12.1% | – | |||
| 3 years | – | – | +21.6% | – | |||
| 5 years | – | – | +15.9% | – | |||
| 7 years | – | – | +22.0% | – | |||
| 10 years | – | – | +13.4% | – | |||
From the plan's own NAV, to 20 Nov 2026. Rank 1 is best. Past returns are no guide to the future.
RiskWorst fall -10.1% · volatility 16.6% a year
Volatility, since launch
16.6%
BSE Healthcare 16.1%
Worst fall
-10.1%
Oct 2026, back by Nov 2026
Up months
58%
last 3 years
Against other pharma and healthcare funds, last 3 years (worst fall: 5 years)
Yearly cost
= 1.25%
About average · average 1.10%
13 of 18
More measures ›Fewer measures ‹
Sharpe ratio, 3 years
N/A
Return above the CRISIL Overnight Index per unit of volatility
Sortino ratio, 3 years
N/A
The same, counting only falls
Alpha vs BSE Healthcare
N/A
Yearly return beyond what its beta explains
Beta vs BSE Healthcare
N/A
Moves this much when the index moves 1%
Share of the index's rises
100%
In months the index rose
Share of the index's falls
110%
In months the index fell; lower is better
Over the last 3 years, from the fund's NAVs against the BSE Healthcare.
Where it ranksAgainst 19 pharma and healthcare funds
Where it ranks
among 19 pharma and healthcare funds, Direct plansLowest cost
13 of 18
Third quarter
| Best over 3 years | 3 years | A year | Cost | Size |
|---|---|---|---|---|
| 1HDFC Pharma and Healthcare Fund | +123.0% | +30.6% | 1.04% | ₹3,666 Cr |
| 2SBI Healthcare Opportunities Fund | +94.4% | +24.8% | 1.00% | ₹6,067 Cr |
| 3Mirae Asset Healthcare Fund | +90.9% | +24.0% | 0.61% | ₹3,562 Cr |
| 4UTI Healthcare Fund | +87.3% | +23.3% | 1.34% | ₹1,433 Cr |
| 5LIC MF Healthcare Fund | +80.9% | +21.9% | 1.38% | ₹96.54 Cr |
| 18Bandhan Healthcare Fund this fund | – | – | 1.25% | ₹325 Cr |
Every fund in the category computed from its own NAV the same way, to 20 Nov 2026. All Pharma and Healthcare funds ›
What stands out
What it holds
37 holdings · as of Aug 2026
- 1Sun Pharmaceutical Industries Ltd10.48%
- 2Cipla Ltd6.38%
- 3Max Healthcare Institute Ltd5.81%
- 4Apollo Hospitals Enterprises Ltd5.64%
- 5Cash, TREPS and repo4.33%
- 6Divi'S Laboratories Ltd4.28%
- 7Aurobindo Pharma Ltd4.14%
- 8Lupin Ltd3.96%
- 9Shilpa Medicare Ltd3.72%
- 10Glaxosmithkline Pharmaceuticals Ltd3.68%
SIP returns of pharma and healthcare funds · All pharma and healthcare funds · Fund screener
About Bandhan Healthcare Fund Direct Plan Growth
Bandhan Healthcare Fund Direct Plan Growth is a Sector Specific - Pharma equity fund from Bandhan AMC Limited, launched on 24 Nov 2025. Its benchmark is the BSE Healthcare Index. The expense ratio is 1.25% a year. It manages ₹325 crore. The NAV was ₹11.69 on 20 Nov 2026.
Questions about Bandhan Healthcare Fund
What is the NAV of Bandhan Healthcare Fund Direct Growth?
The NAV of Bandhan Healthcare Fund Direct Growth was ₹11.69 on 20 Nov 2026. Mutual fund NAVs are published once a day, after markets close.
What is the expense ratio of Bandhan Healthcare Fund Direct Growth?
1.25% a year. It is taken from the fund's assets every day, so the NAV and every return shown are already after this cost.
Can NRIs in the UAE invest in Bandhan Healthcare Fund?
NRIs can generally invest once KYC is complete, paying from an NRE or NRO account. Bandhan Mutual Fund accepts investors living in the US only on conditions and does not accept investors living in Canada, per its own documents checked on 15 Nov 2026. Rules change, so confirm with the fund house.
How are Bandhan Healthcare Fund gains taxed for NRIs?
India taxes gains on equity funds at 20% on units held 12 months or less, and at 12.5% on gains above ₹1.25 lakh a year on units held longer, plus cess and any surcharge. For NRIs the tax is deducted when units are redeemed. The UAE has no personal income tax, and the India UAE tax treaty may apply, so confirm your position with a tax adviser.
Rolling returns shows every period, not just the latest.
Compare every pharma and healthcare fund on returns, volatility, worst fall and cost.
















